Tempus AI Stock (TEM) Hits New 52-Week despite Analyst Downgrade
Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...
Why Tempus AI Inc. (TEM) Went Up on Thursday
We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...
Hosted on MSN10h
Artera partners with Tempus to expand AI cancer test access
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Tempus AI Stock Soars to All-Time High
Tempus AI shares soared to an all-time high Thursday as the tech firm announced a collaboration with the nonprofit Institute ...
What's Going On With Tempus AI Shares Thursday?
Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...
William Blair Downgrades Tempus AI, Inc. (TEM) to Market Perform on Valuation Concerns
We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other AI ...
Tempus AI enters collaboration with Institute for Follicular Lymphoma Innovation
Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...
Le Lézard21h
PhaseV Launches Webinar Series on AI and Data-Driven Clinical Trial Optimization
PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...